The Technical AnalystExchange: STO Sector: Healthcare Industry: Biotechnology
Cline Scientific AB Price, Forecast, Insider, Ratings, Fundamentals & Signals
13.37% SEK0.115
America/New_York / 17 mai 2024 @ 11:29
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 4.78 mill |
| EPS: | -0.100 |
| P/E: | -1.140 |
| Earnings Date: | Apr 18, 2024 |
| SharesOutstanding: | 41.75 mill |
| Avg Daily Volume: | 0.0240 mill |
| RATING 2024-05-17 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | |
| Gr.Profit | n/a | n/a | n/a | |||
| Ebit | n/a | n/a | n/a | |||
| Asset | n/a | n/a | ||||
| Debt | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.140 | sector: PE 19.76 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -1.140 | industry: PE 491.84 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
SEK 0.0885 - 0.141 ( +/- 22.71%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | SEK0.115 (13.37% ) |
| Volume | 0.0399 mill |
| Avg. Vol. | 0.0240 mill |
| % of Avg. Vol | 166.26 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CLINE-B.ST
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CLINE-B.ST
Cline Scientific AB (publ) develops cancer diagnostics and regenerative medicine treatments in Sweden. It develops an allogenic stem cell therapy based on induced pluripotent stem (iPS) cells. The company also develops surface nanotechnology for cell-based products and processes to drive projects within life science into the clinical phase. It has collaboration with AstraZeneca to utilize gradient technology. Cline Scientific AB (publ) was founded in 2012 and is based in Mölndal, Sweden.